Submitted by Anonymous (not verified) on 8 May 2026 - 11:14
Human medicines European public assessment report (EPAR): Rivaroxaban Viatris (previously Rivaroxaban Mylan), rivaroxaban, Date of authorisation: 12/11/2021, Revision: 11, Status: Authorised
Source: